Themis Medicare Ltd Technical Momentum Shifts Amid Mixed Market Signals

Technical Trend and Momentum Overview

The technical trend for Themis Medicare has transitioned from a bullish stance to a mildly bullish one, signalling a tempering of upward momentum. The Moving Averages on the daily chart remain bullish, indicating that short-term price action continues to favour buyers. However, the weekly and monthly indicators present a more varied picture.

The Moving Average Convergence Divergence (MACD) remains bullish on the weekly timeframe, suggesting that momentum is still positive in the near term. On the monthly scale, the MACD is mildly bullish, reflecting a slower but steady upward trend. Conversely, the Know Sure Thing (KST) indicator shows a mildly bearish signal on the weekly chart, hinting at some short-term caution, while it remains mildly bullish on the monthly chart, supporting a longer-term positive bias.

RSI and Bollinger Bands: Neutral to Mildly Bullish Signals

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no definitive signal, indicating neither overbought nor oversold conditions. This neutrality suggests that the stock is consolidating and may be poised for a directional move once momentum picks up.

Bollinger Bands, which measure volatility and price levels relative to recent averages, are mildly bullish on both weekly and monthly charts. This mild bullishness implies that price volatility is contained within an upward trending channel, supporting the possibility of gradual price appreciation.

Price Action and Volume Analysis

Themis Medicare’s current price stands at ₹123.80, slightly down by 0.36% from the previous close of ₹124.25. The stock traded within a range of ₹121.70 to ₹128.15 today, showing some intraday volatility but maintaining a position well above its 52-week low of ₹65.00. However, it remains below its 52-week high of ₹147.99, indicating room for recovery if momentum strengthens.

On the volume front, the On-Balance Volume (OBV) indicator shows no clear trend on weekly or monthly charts, suggesting that volume is not currently confirming price movements. This lack of volume confirmation may limit the strength of any breakout or breakdown in the near term.

Comparative Returns and Market Context

Examining Themis Medicare’s returns relative to the Sensex reveals a mixed performance. Over the past week, the stock has outperformed the benchmark with a 3.90% gain against the Sensex’s 0.92% decline. This outperformance extends over the last month and year-to-date periods, with returns of 17.68% and 23.00% respectively, while the Sensex has declined by 1.47% and 9.71% over the same intervals.

However, longer-term returns paint a less favourable picture. Over three years, Themis Medicare has declined by 22.11%, contrasting with the Sensex’s 17.67% gain. Over five and ten years, the stock’s returns of 11.86% and 121.39% lag behind the Sensex’s 34.19% and 170.71% respectively. This divergence highlights the stock’s volatility and challenges in sustaining long-term growth.

Mojo Score and Grade Implications

Themis Medicare’s Mojo Score currently stands at 24.0, reflecting a Strong Sell rating, which is a downgrade from its previous Sell grade as of 1 September 2026. This downgrade signals increased caution from the MarketsMOJO analytics platform, which factors in a combination of technical, fundamental, and market sentiment data.

The micro-cap status of the company adds an additional layer of risk, as smaller companies often experience higher volatility and lower liquidity. Investors should weigh these factors carefully against the technical signals before making investment decisions.

Technical Indicator Summary and Outlook

Summarising the technical indicators, Themis Medicare exhibits a blend of bullish and bearish signals. The daily moving averages and weekly MACD support a positive near-term outlook, while the weekly KST and neutral RSI readings advise caution. Bollinger Bands’ mild bullishness suggests contained volatility, but the absence of volume confirmation from OBV tempers enthusiasm.

From a Dow Theory perspective, no clear trend is established on weekly or monthly charts, indicating that the stock is in a consolidation phase without a definitive directional bias. This indecision may persist until a catalyst triggers a breakout or breakdown.

Investor Considerations and Final Thoughts

Investors analysing Themis Medicare should consider the stock’s recent technical momentum shift alongside its fundamental and market context. The mildly bullish technical trend and positive short-term momentum indicators offer some encouragement, but the Strong Sell Mojo Grade and mixed signals from other technical tools counsel prudence.

Given the stock’s micro-cap classification and historical underperformance relative to the Sensex over longer periods, risk-averse investors may prefer to monitor for clearer trend confirmation before committing capital. Conversely, those with a higher risk tolerance might view the current consolidation and mild bullish signals as an opportunity to accumulate at relatively attractive levels, anticipating a potential rebound.

Ultimately, the interplay of technical indicators suggests that Themis Medicare is at a crossroads, with the potential for either a sustained recovery or further correction depending on forthcoming market developments and sector dynamics.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today